Neural Noise- At a State Council Information Office press conference on August 26, 2026, China’s Ministry of Industry and Information Technology named brain-computer interfaces among six national “future industries” in the 15th Five-Year Plan (2026–2030), alongside quantum technology, biomanufacturing, hydrogen and nuclear fusion energy, embodied intelligence, and 6G.1
- The designation formally commits state-level policy coordination, standards-setting, and industrial funding to the BCI sector; MIIT’s draft standards roadmap targets more than 40 BCI national standards by 2028 and more than 80 brain-technology standards by 2030.1
- Chinese private-capital markets have moved in advance of the plan: venture funding for Chinese BCI companies reached approximately RMB 6.47 billion (~$890 million) in H1 2026 alone, up from RMB 1.5 billion for all of 2025, making China the second-largest BCI funding market globally behind the United States.2
- China’s National Medical Products Administration had already cleared Neuracle Medical Technology’s NEO invasive motor BCI for commercial sale in March 2026 — the first invasive motor BCI cleared for routine clinical use outside a trial anywhere in the world — and NHSA assigned a reimbursement billing code within 48 hours of clearance.2
- The 15th Five-Year Plan BCI designation follows China listing brain-computer interfaces in ten provincial-level policy documents, with hard numeric targets set for 2030 and with Zhejiang and Beijing as the only regions so far to include BCI items in basic medical insurance reimbursement.1
- The announcement represents the clearest signal yet that Beijing views BCI as a strategic technology on par with quantum and 6G, intensifying the US–China race in a sector where both Neuralink and Science Corp are racing toward commercial approvals.2